Other languages CKD Corporation

Equities

6407

JP3346800000

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-07-12 am EDT			5-day change	1st Jan Change
3,270 ^JPY	-1.65%		-1.06%	+28.74%

Jul. 02	Ardelyx, Inc. Chooses Not to File for TDAPA to Preserve Patient Access to XPHOZAH	CI
Jun. 26	Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ardelyx, Inc. Chooses Not to File for TDAPA to Preserve Patient Access to XPHOZAH	Jul. 02
Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial	Jun. 26
Tan Chong International to Shift from CKD Business Model to CBU Sales Model from Japan	May. 24
AstraZeneca : s'attend à une forte hausse de la maladie rénale	Apr. 15
TVS Supply Chain's Supply of CKD Kits to TVS Motor Crosses 500,000	Apr. 11
Las automotrices chinas abren fábricas en el extranjero en medio de fricciones sobre exportaciones	Mar. 14
Novo Nordisk : l'UE pourrait autoriser Wegovy d'ici Avril	Feb. 23
Novo Nordisk : autorisation de l'UE pour Wegovy d'ici Avril ?	Feb. 23
Disc Medicine Says FDA Grants Fast Track Designation for Investigational Treatment of Chronic Kidney Disease, Anemia	Feb. 20
FDA Adds 'Boxed Warning' for Hypocalcemia Risk to Amgen's Osteoporosis Drug Prolia	Jan. 19
FDA Adds 'Boxed Warning' for Hypocalcemia Risk to Amgen's Osteoporosis Drug Prolia	Jan. 19
AstraZeneca Discontinues Two Phase 3 Evidence Trials of Lokelma in Managing Hyperkalemia	Dec. 01
AstraZeneca : arrêt de deux essais de phase III sur Lokelma	Dec. 01
Miners give FTSE 100 boost thanks to China PMI	Dec. 01
AstraZeneca discontinues two phase III evidence trials for Lokelma	Dec. 01
AstraZeneca Ends Two Late-stage Studies of Hyperkalemia Drug Lokelma on Delayed Schedules	Dec. 01
Stocks called higher; UK house prices fall annually	Dec. 01
AstraZeneca to scrap two trials on drug that curbs potassium	Dec. 01
AstraZeneca Drug Combo Found to Reduce Disease Marker Associated with Chronic Kidney Disease	Nov. 03
AstraZeneca plans next phase of trial on kidney drug combination data	Nov. 03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CKD Corporation

Equities

6407

JP3346800000

Other languages

Filters